Galleri Multi-Cancer Detection Test Integrated into Epic EHR System for Streamlined Access

GRAIL has announced the integration of its multi-cancer early detection test, Galleri®, into the Epic electronic health record (EHR) platform. This development aims to streamline access for healthcare providers across the United States, allowing them to seamlessly order and manage the Galleri® test within their existing workflows. The integration is expected to enhance operational efficiency and improve patient care by simplifying how providers incorporate this advanced cancer screening tool into routine medical practice.

The Galleri® test, designed to detect signals from over 50 types of cancers through a single blood draw, will now be available directly through Epic’s EHR system. Healthcare professionals using Epic can order the test, review results, and coordinate follow-up care without needing separate systems or processes. GRAIL stated that this move aligns with its mission to make early cancer detection more accessible nationwide. By embedding the Galleri® test into one of the most widely used EHR platforms in the U.S., GRAIL seeks to reduce barriers for both patients and providers while supporting earlier diagnosis and treatment planning.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 7, 2026

Author

GOAI